- Dr. Mary Norine Walsh Assumes ACC Presidency @MinnowWalsh @ACCinTouch #ACC17 http://ow.ly/KEH430a3zvm #ACCChapters
- Hadley Wilson, MD, FACC, Elected Chair of ACC Board of Governors @Carolinas #ACC17 #ACCChapters http://ow.ly/Piiv30a3zql
- We're still buzzing about a great #ACC17! What did you find most interesting at the meeting? #ACCChapters
- Get complete coverage of #ACC17 at ACC.org/ACC2017. #ACCChapters
- FOURIER: Evolocumab Significantly Reduces Risk of CV Events http://ow.ly/dP2e30a07II #PCSK9 #cvLipids #cvPrev #ACCPrev #ACC17
- SURTAVI Trial: #TAVR Non-inferior to SAVR in Pts w/ Intermediate #cvSurg Risk http://ow.ly/hhK130a08pB #ACC17 #ACCIC #ACCSurgeons
- SPIRE 1 & SPIRE 2: Safety & Efficacy of Bococizumab in High Risk Pts http://ow.ly/lCgX30a07Yy #ACC17 #PCSK9 #cvLipids #cvPrev #ACCPrev
- Low-Dose Rivaroxaban vs. Aspirin Reduces Recurrent #cvVTE in EINSTEIN CHOICE http://ow.ly/9Nvc30a1R8B #ACC17 #cvCoag #cvPAD #ACCPVD
- CVD-REAL Study: Lower Rates of Hospitalization For #cvCHF in New Users of SGLT-2 Inhibitors http://ow.ly/fBwG30a3h7w #ACC17
- LAAO Shown to Reduce Thromboembolism in #AFib Patients http://ow.ly/9j1C30a37oB #cvLAAoccluder #ACC17
- VISION: Testing for Troponin T Can Spot Unrecognized Heart Injuries After Surgery http://ow.ly/zK8O30a2ZG6 #ACC17 #CVD
- Microbleeds, Neurological Impairment Observed After #TAVR http://ow.ly/Afc130a2Zlk #cathlab #ACC17 #ACCIC
- LEVO-CTS: No Improvement in Primary Outcomes With Levosimendan For #cvSurg http://ow.ly/yY3330a2Zid #ACC17 #ACCSurgeons #ACCIC
- New Research Examines Outcomes of Absorb BVS, OMT and #PCI Approaches http://ow.ly/Uk1z30a22dy #ACC17 #ACCIC #cathlab
- 3 Studies Affirm Advantages of FFR and Instantaneous Wave-Free Ratio http://ow.ly/FTL630a22hs #cvImaging #ACCImaging #ACCIC #cvACS #ACC17
- EBBINGHAUS: No Effect on Neurocognition With Evolucumab http://ow.ly/nHCa30a1QZ9 #ACC17 #cvMetabolic #cvPrev #ACCPrev #PCSK9
- Study Shows No Reduction of Plaque With Synthetic HDL-C Injection http://ow.ly/2Fta30a1RrE #ACC17 #cvPrev #ACCPrev #cvLipids
- REACH: Web-Based Lifestyle Counseling Leads to 10-point Reduction in Systolic BP http://ow.ly/PJyK30a1Ruf #ACC17 #cvLipids #cvPrev #ACCPrev
- GEMINI-ACS-1: Low-dose rivaroxaban doesnt result in higher bleeding in pts already on P2Y12 inhibitor postACS http://ow.ly/VTH630a1Rxi #ACC17
- Video Interview: ORION-1 http://ow.ly/2rFV30a17Tv #ACC17 #cvLipids #cvMetabolic
- SPAIN: Pacemaker Program Can Reduce Dangerous Fainting Episodes http://ow.ly/qxZ430a3784 #ACC17 #cvEP #ACCEP
Check Out Complete ACC.17 Coverage on ACC.org
In case you missed it, the ACC provided coverage of the hottest trials that came out of ACC's Annual Scientific Session (ACC.17) in Washington, DC. To view all the latest science, check out the ACC.17 Meeting Coverage Page at ACC.org/ACC2017. Also, head to ACC's YouTube Page to watch daily wrap-up videos highlighting the hottest trials from each day of ACC.17. Check out archived tweets by searching for the official meeting hashtag #ACC17 or scroll through our live coverage of the meeting via Twitter at @ACCCardioEd. Watch the new "ACC Cardiology Hour," an expert roundtable discussion of the hottest trials from ACC.17. Valentin Fuster, MD, PhD, MACC, hosts Deepak L. Bhatt, MD, MPH, FACC; Anne B. Curtis, MD, FACC; Kim A. Eagle, MD, MACC; Michael J. Mack, MD, FACC; and Donna M. Mancini, MD, in a lively discussion on FOURIER, SPIRE 1 and SPIRE 2, EBBINGHAUS, SURTAVI, iFR-SWEDEHEART, and more. See the video at ACC.org/CardiologyHour.
HHS Delays Start Date for Episode Payment Models
The U.S. Department of Health and Human Services (HHS) announced today that the effective date for the final rule for Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation (CR) Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model has been further delayed until May 20, 2017. This postpones the start date of the EPMs and the CR Incentive Payment Model for three months – from July 1, 2017 to Oct. 1, 2017. In its statement, HHS noted it is seeking comments on the appropriateness of this delay, as well as a further start date delay until Jan. 1, 2018.
According to HHS, the additional three-month delay "is necessary” to allow time for further review and to ensure that the agency "has adequate time to undertake notice and comment rulemaking to modify the policy if modifications are warranted, and to ensure that in such a case participants have a clear understanding of the governing rules and are not required to take needless compliance steps due to the rule taking effect for a short duration before any potential modifications are effectuated." Read more on ACC.org.
ACC Updates AUC For Coronary Revascularization For SIHD Patients
Updated appropriate use criteria (AUC) for coronary revascularization in patients with stable ischemic heart disease (SIHD) contain several important changes from the original version published in 2012. The new criteria, developed by the ACC, the Society for Cardiovascular Angiography and Interventions, The Society of Thoracic Surgeons and the American Association for Thoracic Surgery, along with key specialty and subspecialty societies, were published March 10 in the Journal of the American College of Cardiology. “These new AUC are an important advance in the efforts of the partnering societies to improve the quality of cardiovascular care and deliver the right care to the right patients,” said Writing Committee Chair Manesh R. Patel, MD, FACC. “The document provides a framework for how patients and providers can think about revascularization in the stable setting and will help health systems and medical societies judge quality of care.” Read more on ACC.org.
Focused Update of the Valvular Heart Disease Guideline Released
The ACC and the American Heart Association have released a focused update of guidelines for the treatment of patients with valvular heart disease. The new guidance, which has been updated to reflect the latest research since the last guidelines were published in 2014, was published March 15 in the Journal of the American College of Cardiology. Specifically, the focused update includes changes in indications for antibiotic prophylaxis for infective endocarditis, the use of direct oral anticoagulants among patients with atrial fibrillation and heart valve disease, indications for transcatheter aortic valve replacement, surgical management of patients with primary and secondary mitral regurgitation, and management of patients with a heart valve prosthesis. Read more on ACC.org.
ACC Releases New Guidance For Syncope
The ACC, with the American Heart Association and the Heart Rhythm Society, released the first guideline for the evaluation and management of patients with syncope. The guideline was published March 9 in the Journal of the American College of Cardiology. “Now that we have these guidelines, physicians and clinicians will be able to make better-informed decisions and this will contribute to improved patient outcomes,” said Win-Kuang Shen, MD, FACC, chair of the writing group. Of note, the guideline recommends that if a patient faints, a physician should perform a detailed history and physical examination during the initial evaluation. Using an electrocardiogram during this time may be useful to determine the cause of fainting. People with serious medical conditions that could be related to their fainting should be evaluated and/or treated at a hospital after the initial assessment. Read more on ACC.org.
Training Statement For HF and Transplant Specialists Released
A new training statement from the ACC and numerous partnering societies addresses the competencies required of sub-subspecialists in Advanced Heart Failure and Transplant Cardiology (AHFTC). The document was published March 8 in the Journal of the American College of Cardiology. The training statement complements the recently published Core Cardiovascular Training Statement (COCATS), and outlines the knowledge, skills and experiences that should result from a 12-month training program in AHFTC and defines the competencies required of these trainees. "The document will serve as a foundation upon which the training of cardiologists entering the field of AHFTC can be based, so that patients with advanced heart failure will be optimally treated by skilled and knowledgeable physicians," said Mariell Jessup, MD, FACC, chair of the writing committee. Read more on ACC.org.
Latest Issue of Cardiology Features a Planning Guide for ACC.17
The cover story in the latest issue of Cardiology magazine brings together all the key information about ACC.17 into a comprehensive planning guide. The feature article provides an overview of the present status of reversal agents for the direct-acting oral anticoagulants and some of the persisting misconceptions about these agents. In a Get to Know Your Leaders article, Richard A. Chazal, MD, FACC, reflects on his year as president, including work related to MOC, MACRA, the evolution of the ACC’s governance process, and ACC Accreditation Services. In a Research to Practice article, Thomas M. Maddox MD, MSc, FACC and Robert W. Yeh MD, FACC, outline the NCDR Research to Practice (R2P) initiative and some of its recent successes, including three presentations coming at ACC.17. Get the full issue at ACC.org/Cardiology.
JACC Leadership Page: The Dyad Model and Value-Based Care
In a recent Editor’s Page published in the Journal of the American College of Cardiology (JACC), Richard A. Chazal, MD, FACC, immediate-past ACC president, and Michael J. Montgomery, FACHE, director of the cardiovascular service line, at Lee Health System discuss the use of the dyad model of management for addressing operational excellence and reducing costs, while improving the quality of patient care and enhancing patient experience. In the dyad model, management teams at hospitals and health systems consist of one clinical member and one administrative member, with the goal of leveraging each other’s strengths to advance organizational performance and ultimately save lives. “We have found the dyad model to be valuable in creating a collaborative culture that is built around shared goals and takes into account administrative and clinical needs, all while striving to keep quality of patient care central to all discussions,” they write. Read more.
JACC Editor’s Page: Adding JACC: Basic to Translational Science to the Family
In a recent Editor’s Page published in the Journal of the American College of Cardiology (JACC), Editor-in-Chief Valentin Fuster, MD, PhD, MACC and JACC: Basic to Translational Science Editor-in-Chief Douglas L. Mann, MD, FACC discuss how the newest addition fits into the JACC family and how it adds to the literature. JACC: Basic to Translational Science seeks to publish studies that will lead to new therapies, tracing the arc of scientific discovery from early preclinical studies all the way through phase I and II clinical trials, which are often dismissed by other journals. “JACC: Basic to Translational Science complements both the parent journal and the other sister journals by providing a scientific home for translational research studies that do not necessarily fit within the clinical context of the more established JACC journals,” they write. “We also believe that JACC: Basic to Translational Science uniquely extends the scientific reach of the JACC family of journals by providing a new journalistic home that fosters the arc of translational discovery from ‘molecules to man,’ with the goal of improving outcomes for patients with cardiovascular disease.” Read more.
Your Blueprint For Navigating MACRA and the Quality Payment Program
Implementation of the Quality Payment Program, created by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), is officially underway. As the Quality Payment Program kicks into gear, it’s important for clinicians to have updated and cardiovascular-specific information at their fingertips. The ACC's new and improved MACRA Information Hub on ACC.org helps cardiovascular professionals understand the new Medicare payment system, implement the Quality Payment Program and explore available resources. The mobile-friendly MACRA Hub includes information on common MACRA terms; the Merit-Based Incentive Payment System and Advanced Alternative Payment Model pathways; requirements for the Quality, Improvement Activities, Advancing Care Information and Cost categories; key program dates; cardiovascular quality measures; and more. Visit ACC.org/MACRA.
Quit Smoking Infographic Now Available
Smoking is the second leading cause of cardiovascular disease, following high blood pressure. People who smoke are up to six times more likely to suffer a heart attack than non-smokers. However quitting is not easy and patients are often complaining about not knowing how to stop smoking. The ACC’s CardioSmart team has developed an infographic explaining how smoking affects cardiovascular health and what are the best ways to stop smoking. The Quit Smoking Infographic can be downloaded for free, along with other CardioSmart infographic posters that can be used as point-of-care graphics for your waiting and exam rooms. Visit CardioSmart.org/QuitSmoking for more tools and resources to help your patients stop smoking, including a video and steps for quitting.